Doctor profile · Federal record

Dr. Rachel Romero, MD

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Concord, NC

  • NPI 1558603910
  • Accepts Medicare
  • MIPS 92.1 / 100 · 2023
  • 13 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
200 Medical Park Dr, Ste 330
Concord, NC 280252982
(704) 403-1308
Mailing address
Po Box 19305
Charlotte, NC 282199305

Credentials & registration

NPPES · NUCC
NPI registered
March 2013 — 13 yrs on file
Profile last updated
July 15, 2024
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
North Carolina #2016-00574

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1558603910. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
31,652
Distinct HCPCS
10
Medicare allowed
$516,537
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 17,600 16 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 4,100 19 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 4,000 12 $13
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,730 19 $33
J0897 Injection, denosumab, 1 mg 2,040 27 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 261 141 $121
96372 Injection of drug or substance under skin or into muscle 148 55 $14
96415 Administration of chemotherapy into vein, each additional hour 111 37 $27
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 110 47 $60
J3489 Injection, zoledronic acid, 1 mg 105 21 $9

In context: peer comparison

Among 3 peers in Concord Rheumatology Physician, average services per provider: 1,440. This provider delivers 22× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$72
Transactions
2
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 2 $71.70

By nature of payment

Education
$55
Food and Beverage
$17

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,791
Patients
512
Total drug cost
$1,711,133
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 425 118 $24,376
Methotrexate (Methotrexate Sodium) Brand 252 89 $9,753
Prednisone Generic 233 85 $2,021
Leflunomide Generic 131 39 $7,540
Tramadol Hcl Generic 124 26 $1,158
Celecoxib Generic 98 32 $4,546
Humira(Cf) Pen (Adalimumab) Brand 98 13 $1,017,836
Meloxicam Generic 79 25 $450
Allopurinol Generic 69 22 $1,609
Orencia Clickject (Abatacept) Brand 54 0 $309,605

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Rachel Romero's medical specialty?
Dr. Rachel Romero practices Rheumatology Physician in Concord, NC.
Where does Dr. Rachel Romero practice?
Dr. Rachel Romero practices at 200 Medical Park Dr, Concord, NC 280252982. Office phone: 7044031308.
What is Dr. Rachel Romero's NPI?
Dr. Rachel Romero's National Provider Identifier (NPI) is 1558603910, issued by NPPES.
Does Dr. Rachel Romero accept Medicare assignment?
Yes. Dr. Rachel Romero accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Romero commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.